News

 

FDA Schedules Public Meeting on Paclitaxel Use in PAD

April 22, 2019 -- The FDA announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee will convene a public meeting to discuss and make recom…

Multisociety Position Statement Supports PAE to Treat Lower Urinary Tract Symptoms Attributed to BPH

April 19, 2019 -- A multisociety consensus position statement on prostate artery embolization (PAE) for treatment of lower urinary tract symptoms (LUTS) secondary to benign pr…

Cook Medical Provides Patient-Level Paclitaxel Data From Zilver PTX Randomized Controlled Trial

April 18, 2019 -- Cook Medical announced that patient-level data from the Zilver PTX randomized controlled trial (RCT) of the company's paclitaxel-eluting peripheral stent…

Two-Year-Data Presented From BIOLUX P-III Registry of Biotronik's Passeo-18 Lux DCB

April 18, 2019 -- Biotronik announced that 2-year data from the BIOLUX P-III all-comers registry of the company's Passeo-18 Lux drug-coated balloon (DCB) were presented at…

Two-Year Data Presented for ESAR Combining Medtronic's Endurant Stent Graft and Heli-FX EndoAnchor Systems

April 17, 2019 -- Medtronic announced the presentation of new data for endosuture aneurysm repair (ESAR) in patients with abdominal aortic aneurysms (AAAs) with the Endurant I…

Thirty-Day Safety and Efficacy Data Presented for Medtronic's Valiant Navion TEVAR System

April 17, 2019 -- Medtronic announced the presentation of new data for its Valiant Navion thoracic stent graft system for thoracic endovascular aneurysm repair (TEVAR). T…

Click here for more News coverage

Paclitaxel In PAD

Current Supplement

Sponsored by GORE & ASSOCIATES

Looking at the Full Scope of PAD

Cases, Techniques, and Economic Considerations for Complex Disease.

Current European Supplement

Sponsored by EUMEDICA

Thrombolysis for Peripheral Arterial Thrombosis

Leading French experts discuss the place of thrombolysis in the modern era.

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 

Featured Center

 

Embolization

 
Vascular Market Price  Change
Abbott Laboratories $74.40  0.64%
AstraZeneca PLC $38.66  -0.37%
Avinger $0.54  -7.79%
Becton Dickinson and Co $225.13  -1.21%
Boston Scientific Corporation $34.86  -0.71%
Cardinal Health $45.14  -1.88%
Cardiovascular Systems Inc. $34.55  1.14%
Edwards Lifesciences Corp. $178.20  0.53%
Endologix Inc. $6.05  4.49%
Johnson and Johnson $137.53  0.01%
Vascular Market Price  Change
Medtronic, Inc. $84.14  -0.09%
Merit Medical Systems, Inc. $57.34  -0.55%
Penumbra, Inc. $128.17  -0.62%
Philips $39.77  0.05%
Ra Medical Systems $4.27  5.43%
Silk Road Medical $34.05  0.18%
Stryker $182.77  1.39%
Teleflex Inc. $274.24  -1.01%
The Medicines Company $28.17  0.54%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.